Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group
about
The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceTamoxifen and risk of idiopathic venous thromboembolismCurrent and potential future drug treatments for osteoporosis.Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.Adjuvant Endocrine Therapy in Early Postmenopausal Breast CancerA comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort studyTime dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trialMeta-analysis of vascular and neoplastic events associated with tamoxifenHyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.Safety of aromatase inhibitors in the adjuvant setting.Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanismsBreast cancer as an acquired thrombophilic state.Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.Tamoxifen reduces plasma homocysteine levels in healthy women.Nanotamoxifen Delivery System: Toxicity Assessment After Oral Administration and Biodistribution Study After Intravenous Delivery of Radiolabeled Nanotamoxifen.Myocardial infarction risk and tamoxifen therapy for breast cancerIs tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a reviewAssessing risk of venous thromboembolism in the patient with cancer.Update on the use of aromatase inhibitors in early-stage breast cancer.Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic reviewAssociation of tamoxifen resistance and lipid reprogramming in breast cancer
P2860
Q26830744-BD93646D-51C0-4C87-975C-94C2CBCF93A4Q28368257-124A82BD-2E60-4177-8907-6873A58E273DQ33579316-067AF749-357A-4820-9BF2-70F12B404D50Q33649441-2C9DE0AF-5C82-426B-96EA-43C3372450CCQ34096283-E7DAF948-42C6-430E-9AA7-0095DF3A8E7CQ34252972-C5953253-8975-4D98-9980-864770DF19A9Q34727307-E1653512-72AB-4C21-BFBF-52E3AB33C037Q34742590-EC46796D-8546-4151-8790-896A427A4CEBQ35045916-C9C970DB-CE0F-4F41-A629-7962DD3544A8Q36026543-E0A4E33B-953D-4756-BD3E-82A2451D68B0Q36054383-D91039ED-9008-4DC3-8CDA-EE45FB0A9AF6Q36092001-2C90E086-197D-4E95-986F-B8DF430D1978Q36115270-4C5A95AA-BBC2-4069-B1F0-815C5B636604Q36229869-1027A9A0-95D8-4612-8AC9-768283B6B330Q36292930-BF400808-BED9-4D4F-885E-86BF821C764CQ36508458-6250B1C9-BE2D-4A3E-A8C9-5059D050641EQ36616900-0704172E-F24C-4F17-8831-61CB0AB22E69Q36618977-74C51267-0D39-4CB7-A54A-82AF5DCB9994Q36887091-41F280E3-3C19-4772-8578-54FAAC91593CQ37354647-60722703-769F-457D-9CC4-A510C01C86ABQ37393394-7FD770CB-2B1D-4E17-BF5F-119C2223540EQ37467243-D2FFF0A1-10C0-4F29-A567-1614D2601F5DQ57293528-31A36117-D49C-4809-9FC3-A832CB70742BQ58707140-D094032C-FD00-4020-B11F-F83FEF215833
P2860
Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@ast
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@en
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@nl
type
label
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@ast
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@en
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@nl
prefLabel
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@ast
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@en
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@nl
P2093
P2860
P1433
P1476
Cardiac and vascular morbidity ...... ish Cancer Trials Breast Group
@en
P2093
A P Forrest
C C McDonald
F E Alexander
H J Stewart
P2860
P304
P407
P577
1995-10-14T00:00:00Z